LAT Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29876
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
between 212 and 262
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for LAT Antibody
Immunoprecipitation:LAT AntibodyNBP3-29876] -
Immunoprecipitation:LAT AntibodyNBP3-29876] -Detection of human LAT by western blot of immunoprecipitates. Samples: Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from Jurkat cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LAT antibody (NBP3-29876 lot 1) used for IP at 1 µg per reaction. LAT was also immunoprecipitated by rabbit anti-LAT antibody BL24655. For blotting immunoprecipitated LAT, NBP3-29876 was used at 0.04 mg/ml. Detection: Chemiluminescence with an exposure time of 1 second.Applications for LAT Antibody
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
Tris-citrate/phosphate pH 7 -8.
Preservative
0.09% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: LAT
Long Name
Linker for Activation of T cells
Alternate Names
pp36
Gene Symbol
LAT
Additional LAT Products
Product Specific Notices for LAT Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...